PMC:7463108 / 4046-4394 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T9","span":{"begin":319,"end":327},"obj":"Disease"}],"attributes":[{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"pending on the amount of tolerance developed) and the probability of overdose (Becker and Fiellin 2020; Wakeman et al. 2020). By virtue of its greater safety profile and decreased likelihood for abuse (Bell and Strang 2020), the use of buprenorphine via telemedicine has become advantageous for managing OUD during the COVID-19 pandemic (Leppla and"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T85246","span":{"begin":79,"end":85},"obj":"http://purl.obolibrary.org/obo/CLO_0009882"},{"id":"T25029","span":{"begin":267,"end":270},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"pending on the amount of tolerance developed) and the probability of overdose (Becker and Fiellin 2020; Wakeman et al. 2020). By virtue of its greater safety profile and decreased likelihood for abuse (Bell and Strang 2020), the use of buprenorphine via telemedicine has become advantageous for managing OUD during the COVID-19 pandemic (Leppla and"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T5","span":{"begin":236,"end":249},"obj":"Chemical"}],"attributes":[{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_3216"}],"text":"pending on the amount of tolerance developed) and the probability of overdose (Becker and Fiellin 2020; Wakeman et al. 2020). By virtue of its greater safety profile and decreased likelihood for abuse (Bell and Strang 2020), the use of buprenorphine via telemedicine has become advantageous for managing OUD during the COVID-19 pandemic (Leppla and"}

{"project":"LitCovid-PubTator","denotations":[{"id":"65","span":{"begin":236,"end":249},"obj":"Chemical"},{"id":"71","span":{"begin":69,"end":77},"obj":"Disease"},{"id":"72","span":{"begin":79,"end":85},"obj":"Disease"},{"id":"73","span":{"begin":319,"end":327},"obj":"Disease"}],"attributes":[{"id":"A65","pred":"tao:has_database_id","subj":"65","obj":"MESH:D002047"},{"id":"A71","pred":"tao:has_database_id","subj":"71","obj":"MESH:D062787"},{"id":"A72","pred":"tao:has_database_id","subj":"72","obj":"MESH:D009224"},{"id":"A73","pred":"tao:has_database_id","subj":"73","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"pending on the amount of tolerance developed) and the probability of overdose (Becker and Fiellin 2020; Wakeman et al. 2020). By virtue of its greater safety profile and decreased likelihood for abuse (Bell and Strang 2020), the use of buprenorphine via telemedicine has become advantageous for managing OUD during the COVID-19 pandemic (Leppla and"}

{"project":"LitCovid-sentences","denotations":[{"id":"T35","span":{"begin":119,"end":125},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"pending on the amount of tolerance developed) and the probability of overdose (Becker and Fiellin 2020; Wakeman et al. 2020). By virtue of its greater safety profile and decreased likelihood for abuse (Bell and Strang 2020), the use of buprenorphine via telemedicine has become advantageous for managing OUD during the COVID-19 pandemic (Leppla and"}

{"project":"2_test","denotations":[{"id":"32876803-31420089-62957825","span":{"begin":218,"end":222},"obj":"31420089"}],"text":"pending on the amount of tolerance developed) and the probability of overdose (Becker and Fiellin 2020; Wakeman et al. 2020). By virtue of its greater safety profile and decreased likelihood for abuse (Bell and Strang 2020), the use of buprenorphine via telemedicine has become advantageous for managing OUD during the COVID-19 pandemic (Leppla and"}